Article Details

FDA gives Amgen priority review for asthma treatment

Retrieved on: 2021-07-09 20:00:52

Tags for this article:

Click the tags to see associated articles and topics

FDA gives Amgen priority review for asthma treatment. View article details on hiswai:

Excerpt

Tezepelumab is being developed by Amgen in collaboration with AstraZeneca. According to a press release, AstraZeneca leads development while ...

Article found on: www.pacbiztimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up